Edition:
United States

Pixium Vision SA (PIX.PA)

PIX.PA on Paris Stock Exchange

6.65EUR
24 Mar 2017
Change (% chg)

€-0.19 (-2.78%)
Prev Close
€6.84
Open
€6.80
Day's High
€6.84
Day's Low
€6.65
Volume
9,252
Avg. Vol
13,089
52-wk High
€9.29
52-wk Low
€5.22

Latest Key Developments (Source: Significant Developments)

Pixium Vision FY revenue falls to 2.5 million euros
Monday, 20 Feb 2017 01:00am EST 

Pixium Vision SA : FY operating loss 12.5 million euros ($13.26 million) versus loss of 15.7 million euros year ago . FY revenue 2.5 million euros versus 3.3 million euros year ago . 2016 closing cash position: 14.2 million euros .FY net loss of 12.4 million euros versus loss of 15.6 million year ago.  Full Article

Pixium Vision receives NUB innovation reimbursement status-1 in Germany
Tuesday, 14 Feb 2017 01:00am EST 

Pixium Vision SA :Receives NUB innovation reimbursement status-1 for 150 electrode IRIS II bionic system in Germany.  Full Article

Pixium Vision hits 10 patient implantation in Iris II clinical trial
Monday, 16 Jan 2017 01:00am EST 

Pixium Vision SA :Pixium vision achieves implantation of 10 patients in its clinical trial with its innovative 150 electrodes Iris II bionic vision system.  Full Article

Pixium Vision 9M operating revenue down at 1.9 million euros
Thursday, 27 Oct 2016 01:00am EDT 

Pixium Vision SA : 9M cash consumption reduced by 50 pct compared to prior year .9M operating revenue 1.9 million euros ($2.07 million) versus 2.7 million euros year ago.  Full Article

Pixium Vision announces CE market approval of Iris II
Monday, 25 Jul 2016 01:11am EDT 

Pixium Vision SA :Pixium Vision announces CE market approval of Iris II, its first bionic vision system.  Full Article

Pixium Vision H1 net loss narrows to 6.9 million euros
Wednesday, 20 Jul 2016 01:00am EDT 

Pixium Vision SA : H1 net loss EUR 6.9 million ($7.60 million)versus loss EUR 8.0 million year ago . H1 operating loss EUR 7.0 million versus loss of EUR 8.0 million year ago . H1 revenue EUR 1.4 million versus EUR 1.7 million year ago . At june 30, 2016, pixium vision had a positive net cash position of EUR 16.2 million .Expects first in human implantation of prima before the end of 2016 as part of a feasibility study.  Full Article

Pixium Vision receives trial approval for 150 electrode IRIS II bionic vision system
Tuesday, 31 May 2016 01:00am EDT 

Pixium Vision SA : Pixium Vision receives clinical trial approval from UK regulatory authority for 150 electrode IRIS II bionic vision system .Subject to CE mark approval timing, commercialisation is expected to start in H2 2016.  Full Article

Pixium Vision and research partners report signiprogress on Prima
Wednesday, 4 May 2016 01:00am EDT 

Pixium Vision SA:Pixium Vision and research partners report significant progress on Prima, a tiny wireless sub-retinal implant during ARVO.  Full Article

Pixium Vision confirms FY 2016 guidance
Wednesday, 27 Apr 2016 12:50am EDT 

Pixium Vision SA:Confirms operational outlook including CE mark approval of IRIS II in Europe by mid-2016.Confirms operational outlook including first in human implantation of Prima in a feasibility study before the end of 2016.  Full Article

Pixium Vision gets clinical trial approval from German regulator
Tuesday, 16 Feb 2016 12:50am EST 

Pixium Vision SA:Receives approval from German regulatory authority to implant 150 electrode Iris II in clinical trial.Subject to CE mark approval timing, Iris II commercialization is expected to start in mid-201.  Full Article

More From Around the Web

BRIEF-Pixium Vision FY revenue falls to 2.5 million euros

* FY operating loss 12.5 million euros ($13.26 million) versus loss of 15.7 million euros year ago